In this episode of The Beef Podcast Show, Dr. Rob Hunter, CEO of One Medicine Consulting, unpacks the complexities of veterinary pharmacology, product development, and regulatory challenges in the beef industry. With over 30 years of experience, he breaks down key concepts like generics, bioequivalents, and biowaivers while addressing common concerns around quality and efficacy. Tune in for a deeper understanding of the regulatory landscape for animal health products. Listen now on all major platforms!

"Generics must meet bioequivalence standards to ensure they perform the same as pioneer pharmaceutical products."

Meet the guest: Dr. Rob Hunter, CEO of One Medicine Consulting, earned his M.S. in Veterinary Physiology from Texas A&M University and his Ph.D. in Veterinary Pharmacology from Louisiana State University. With 30+ years in veterinary drug development, he has contributed to major pharmaceutical advancements for livestock and companion animals. A recognized expert in pharmacokinetics, veterinary bioequivalence, and human food safety, he has represented the U.S. veterinary pharmaceutical industry on various global committees. He also serves on the editorial boards for several prominent journals in the field.

What you will learn:

(00:00) Highlight
(01:40) Introduction
(07:24) CVM and bioequivalence
(08:53) Considerations on generics
(12:13) Pioneer vs. generics
(16:44) Pharmaceutical development changes
(21:14) Challenges in animal health
(25:37) Final three questions

The Beef Podcast Show is trusted and supported by innovative companies like:

Virbac

- Lallemand

- Pro Earth Animal Health

- bioMérieux

- dsm-firmenich

𝗟𝗶𝘀𝘁𝗲𝗻 𝗼𝗻 𝗔𝗽𝗽𝗹𝗲 𝗣𝗼𝗱𝗰𝗮𝘀𝘁𝘀, 𝗦𝗽𝗼𝘁𝗶𝗳𝘆 𝗼𝗿 𝗮𝗻𝘆 𝗺𝗮𝗷𝗼𝗿 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺.

Website: The Beef Podcast Show

Instagram: The Beef Podcast Show

LinkedIn: The Beef Podcast Show

Dr. Rob Hunter: Veterinary Pharmaceutical Approval | Ep. 121